コンテンツへスキップ
Merck
  • ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

The American journal of gastroenterology (2013-04-10)
Evan S Dellon, Nirmala Gonsalves, Ikuo Hirano, Glenn T Furuta, Chris A Liacouras, David A Katzka
要旨

Esophageal eosinophilia and eosinophilic esophagitis (EoE) are increasingly recognized and prevalent conditions, which now represent common clinical problems encountered by gastroenterologists, pathologists, and allergists. The study of EoE has become a dynamic field with an evolving understanding of the pathogenesis, diagnosis, and treatment. Although there are limited data supporting management decisions, clinical parameters are needed to guide the care of patients with eosinophilic-esophageal disorders. In this evidence-based review, recommendations developed by adult and pediatric gastroenterologists are provided for the evaluation and management of these patients. New terminology is emphasized, particularly the concepts of esophageal eosinophilia and proton-pump inhibitor-responsive esophageal eosinophilia (PPI-REE) as entities distinct from EoE.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
プロピオン酸フルチカゾン, ≥98% (HPLC), powder
プロピオン酸フルチカゾン, European Pharmacopoeia (EP) Reference Standard